Search

Your search keyword '"Dart RA"' showing total 89 results

Search Constraints

Start Over You searched for: Author "Dart RA" Remove constraint Author: "Dart RA"
89 results on '"Dart RA"'

Search Results

1. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

2. Treatment of systemic hypertension in patients with pulmonary disease: COPD and asthma.

4. Estimating the efficacy of pharmacogenomics over a lifetime.

5. Validating cuffless continuous blood pressure monitoring devices.

7. Medical records-based chronic kidney disease phenotype for clinical care and "big data" observational and genetic studies.

8. Evaluating the impact of motion artifact on noninvasive blood pressure devices.

9. Addressing the wide-range cuff dilemma.

11. Treatment-Related Cardiovascular Outcomes in Patients with Symptomatic Subclavian Artery Stenosis.

12. Evaluating electronic health record data sources and algorithmic approaches to identify hypertensive individuals.

13. Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association.

14. A Robust e-Epidemiology Tool in Phenotyping Heart Failure with Differentiation for Preserved and Reduced Ejection Fraction: the Electronic Medical Records and Genomics (eMERGE) Network.

15. Characteristics and long-term follow-up of participants with peripheral arterial disease during ALLHAT.

16. Public-use blood pressure measurement: the kiosk quandary.

17. Oscillometric blood pressure: calculated risk or reward.

18. Blood pressure control and cardiovascular outcomes in normal-weight, overweight, and obese hypertensive patients treated with three different antihypertensives in ALLHAT.

19. Formation of community-based hypertension practice networks: success, obstacles, and lessons learned.

21. Cardiovascular risk in patients without known cardiovascular disease.

22. Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?

23. The use of dietary supplements and their association with blood pressure in a large Midwestern cohort.

24. Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

25. Expression of the renin-angiotensin system in a human placental cell line.

26. Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.

27. Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).

28. Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center.

29. Palliative medicine referral in patients undergoing continuous renal replacement therapy for acute kidney injury.

30. Association of B-type natriuretic Peptide levels with estimated glomerular filtration rate and congestive heart failure.

32. Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension.

33. Heart failure in ALLHAT: did blood pressure medication at study entry influence outcome?

34. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

35. Secondary hypertension: current diagnosis and treatment.

36. NPHS2 variation in sporadic focal segmental glomerulosclerosis.

37. Specific receptor for angiotensinogen on human renal cells.

39. Small molecule antagonists of the TGF-beta1/TGF-beta receptor binding interaction.

41. Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population.

42. Palliative care.

43. The association of hypertension and secondary cardiovascular disease with sleep-disordered breathing.

44. Citizen Congress takes shape.

45. Obesity and the risk of heart failure.

46. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.

47. The postoperative period summary.

48. New guidelines for prevention, detection, evaluation, and treatment of hypertension: Joint National Committee VI.

50. The clinical utility of ambulatory blood pressure monitoring in a multispecialty clinic setting.

Catalog

Books, media, physical & digital resources